Inhibitors of cholesteryl ester transfer protein – a new approach to coronary artery disease

By Doggrell Sheila A  

Expert Opinion on Investigational Drugs, Vol. 15, Iss. 2, 2006-02 ,pp. : 99-106

Informa Healthcare

Access to resources Recommend Favorite

Atorvastatin affects low density lipoprotein and non-high density lipoprotein cholesterol relations with apolipoprotein B in type 2 diabetes mellitus: modification by triglycerides and cholesteryl ester transfer protein

By Kappelle Paul JWH   Zwang Louwerens   Huisman Menno V   Banga Jan Dirk   Sluiter Wim J   Dallinga-Thie Geesje M   Dullaart Robin PF  

Expert Opinion on Therapeutic Targets, Vol. 13, Iss. 7, 2009-07 ,pp. : 743-751

Informa Healthcare

Access to resources Recommend Favorite

Cholesteryl ester transfer protein inhibitors

By Shinkai H.  

Expert Opinion on Therapeutic Patents, Vol. 11, Iss. 5, 2001-05 ,pp. : 739-745

Informa Healthcare

Access to resources Recommend Favorite

Cholesteryl Ester Transfer Protein (CETP) Inhibitors

By  

Current Topics in Medicinal Chemistry, Vol. 9, Iss. 5, 2009-04 ,pp. : 419-427

Bentham Science Publishers

Access to resources Recommend Favorite

The Mechanism of Lymphatic Access of Two Cholesteryl Ester Transfer Protein Inhibitors (CP524,515 and CP532,623) and Evaluation of Their Impact on Lymph Lipoprotein Profiles

By Trevaskis Natalie   Shanker Ravi   Charman William   Porter Christopher  

Pharmaceutical Research, Vol. 27, Iss. 9, 2010-09 ,pp. : 1949-1964

Springer Publishing Company

Access to resources Recommend Favorite